drugset / Trial / NCT01411670
Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the effects on systemic hemodynamics, microcirculation and organ function of human Protein C concentrate in patients with sepsis and septic shock.
Timeline
- Start
- 2011-01
- Primary completion
- 2015-02
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Drotrecogin alfa (activated) | Protein / enzyme biologic | 24 ug/kg | — |
| Subject | Human protein C concentrate | Protein / enzyme biologic | 3 iu/kg | — |